View
Tube
search
Sign in
Sign up
Subscriptions
VJHemOnc – Video Journal of Hematology & HemOnc
ERIC 2024
61 views
85 items
Last updated on Dec 5, 2024
public playlist
VJHemOnc – Video Journal of Hematology & HemOnc
1:53
Challenges in developing immunotherapies for CLL compared to other hematologic malignancies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:21
The potential of adding anti-CD20 antibodies to acalabrutinib and venetoclax in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:58
Improving the long-term safety of CLL treatment
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:59
Treating R/R CLL: the value of BTKis and venetoclax
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:20
Barriers to the implementation of MRD-guided treatment into CLL clinical practice
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:48
B-cell receptor signaling proteins as biomarkers of progression in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:44
The main barriers to treatment access for patients with CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
7:25
International perspectives on the management of CLL and the Lymphoma Coalition Global Patient Survey
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:12
Testing drugs in isolated cells from patients with CLL: advances and limitations
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:57
Developing in vitro models of CLL: challenges and recommendations
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:23
Mechanical forces in the CLL microenvironment and the importance of modeling them in vitro
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:41
Metabolism in CLL cells: its dynamic nature and influence on the microenvironment
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:38
The role of nurse-like cells in the CLL microenvironment
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:52
The potential of targeting non-malignant cells in the CLL microenvironment
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:40
The clinical manifestations of CLL: classical and constitutional symptoms
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:00
Getting involved in real-world studies for CLL through ERIC
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:22
A study showing that treatment is not always necessary for duodenal-type follicular lymphoma
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:41
The ERIC Patient Empowerment Program: understanding the medical and psychosocial needs of patients
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:21
The CLL patient journey: improving communication between physicians and patients
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:32
Pirtobrutinib versus covalent BTKis and advice for managing toxicities
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
4:47
A study investigating the incidence of clonal hematopoiesis-related mutations in low-count MBL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:04
The current limitations of mouse models of CLL: moving towards humanized models
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:06
Key considerations when treating patients with CLL who have pre-existing cardiovascular disease
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:17
The evolution of frontline treatment for CLL: from chemoimmunotherapy to targeted agents
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:13
Overcoming CAR-T resistance in CLL: combining with ibrutinib
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:20
CAR T-cells and bispecific antibodies in the treatment of double refractory CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:30
Is there a future for PI3Kis in CLL?
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:19
A pilot trial investigating a digital health intervention in patients with CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:58
Key prognostic markers in CLL: TP53, del(17p), and high complexity karyotype
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:37
The evolution of CLL treatment and novel approaches being explored
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:29
Data-driven medicine in CLL: the CLL treatment infection model
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:46
An ongoing study investigating stereotypy in CLL and characterizing major stereotyped subsets
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:54
Updates to the ERIC recommendations on immunoglobulin heavy variable gene analysis in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:56
Key stereotype subsets of BcR immunoglobulin associated with worse outcomes in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:09
The advancements and remaining challenges in precision medicine for CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:34
A study investigating the three-dimensional structure and interactions of BcRs in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:57
The central role of BcR signaling in the pathogenesis of CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:15
Engineering stromal cells to express T-cell factors to induce CLL cell proliferation
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:55
Reporting immunoglobulin gene analysis in CLL: updates to the ERIC guidelines
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:16
Immunoglobulin gene arrangements as clonal markers in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:00
Improving treatment access for patients with CLL in Taiwan
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:25
Advances in targeted therapies and combination approaches for the treatment of CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:04
Key considerations when referring a patient with CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:24
The potential role of non-covalent BTKis in mitigating covalent BTKi resistance
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:01
Exploring the biological mechanisms driving MBL progression to CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:44
Advances in mouse models for studying CLL and Richter's transformation
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:45
The origin of cells of Richter's transformation and the importance of early detection
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:10
A study investigating the incidence of treatment-emergent autoimmune cytopenias in CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:56
Autoimmune cytopenias in CLL and the impact of targeted therapies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:34
The mutational profile in patients with CLL treated with acalabrutinib or ibrutinib
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:22
Targeting B-cell receptor signaling with BTK degraders to treat CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:43
The importance of understanding cellular functionality to develop biological therapies for CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:44
The structure and function of BCRs in the biology of CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:08
The VENICE-1 trial: venetoclax monotherapy in R/R CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
5:40
Recommendations for biomarker analysis in CLL: updates from ERIC 2024
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:40
Challenges in monitoring for cardiotoxicity when treating patients with CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:16
The efficacy of CAR T-cell therapy in Richter’s transformation
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:12
Pericardial adverse events associated with BTKis in CLL: insights from two landmark trials
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:26
Prognostic and predictive biomarkers in CLL and their potential in guiding treatment decisions
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:28
Addressing gaps in the treatment and diagnosis of CLL in low- and middle-income countries
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:47
A study investigating sonrotoclax in R/R and treatment-naïve CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:37
The 2024 update to the NCCN guidelines for CLL/SLL: coming soon
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:43
Is MRD ready to be used in the clinic to guide CLL treatment decisions?
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:24
The new concept of glutamine addiction in CLL and how it may contribute to drug resistance
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:54
The role of metabolic programming in CLL biology and the importance of studying lymph node cells
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:52
A study investigating the efficacy of CAR-T therapy in Richter's transformation
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:17
A study investigating outcomes for a rare subgroup of CLL with CNS involvement
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:42
The future of CLL treatment: aiming for long-lasting remission
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:08
Barriers to progressing CLL treatment in Taiwan: treatment access and biomarkers
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:08
CLL in Taiwan: prevalence, pathogenesis, and clinical practice
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
8:25
Addressing the inequity in CLL research in Nigeria and other restricted-resource settings
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:26
The management of CLL in Nigeria: barriers and initiatives for improved understanding and care
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:43
Exploring the role of non-coding RNAs in CLL biology
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:40
The importance of measuring QoL outcomes in CLL clinical trials
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:19
Challenges in translating molecular research into clinical practice for CLL treatment
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
6:53
Addressing global disparities in the treatment and diagnosis of CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:59
The tests that are needed to make a definitive diagnosis of CLL
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:43
The co-administration of bispecific antibodies and CAR T-cells in CLL: an in vivo study
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:13
Monitoring patients with CLL on ibrutinib-based therapies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:45
Long-term survival of patients with CLL treated with ibrutinib compared to age-matched controls
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:51
BTK degraders for CLL: agents that are currently in development
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:44
The impact of liso-cel approval on the CLL treatment landscape and barriers to its use
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:55
A model including CD49d expression to predict outcomes in patients with CLL treated with ibrutinib
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
6:54
Biomarker-guided treatment of CLL in the chemo-free era
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:08
Looking forward to the 2024 ERIC International Meeting
0 views
0
